Literature DB >> 23009302

Impact of a managed controlled-opioid prescription monitoring program on care coordination.

Arsenio M Gonzalez1, Andrew Kolbasovsky.   

Abstract

INTRODUCTION: Inappropriate opioid medication utilization has grown tremendously in recent years. Managed care organizations have the opportunity to identify potential opioid misuse and implement care coordination interventions.
METHODS: This randomized controlled study evaluated the impact of providing actionable information to prescribers of members who received opioid prescriptions from 3 or more prescribers at 3 or more pharmacies in a 3-month identification period. Impact was assessed through change in number of prescribers, dispensing pharmacies, and filled opioid prescriptions over a 1-year period following identification.
RESULTS: Members randomly assigned to the intervention group demonstrated greater reductions in the number of prescribers (23.98%), dispensing pharmacies (16.28%), and filled opioid prescriptions (15.25%) over the 1-year period. Regression analyses identified group assignment and the number of opioid prescribers in the 3-month identification period as statistically significant predictors of reductions in the number of prescribers, pharmacies, and filled prescriptions.
CONCLUSIONS: This intervention provided action-able information to prescribers regarding member opioid utilization, in addition to available managed care resources. It resulted in significantly greater reductions in the number of prescribers, pharmacies, and prescriptions compared with a general information letter notifying prescribers of available managed care resources. Implementation of this intervention has the potential to enhance coordination of care for members potentially at risk for poor health outcomes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23009302

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  7 in total

Review 1.  What we know, and don't know, about the impact of state policy and systems-level interventions on prescription drug overdose.

Authors:  Tamara M Haegerich; Leonard J Paulozzi; Brian J Manns; Christopher M Jones
Journal:  Drug Alcohol Depend       Date:  2014-10-14       Impact factor: 4.492

2.  Payments For Opioids Shifted Substantially To Public And Private Insurers While Consumer Spending Declined, 1999-2012.

Authors:  Chao Zhou; Curtis S Florence; Deborah Dowell
Journal:  Health Aff (Millwood)       Date:  2016-05-01       Impact factor: 6.301

3.  Effect of Automated Prescription Drug Monitoring Program Queries on Emergency Department Opioid Prescribing.

Authors:  Benjamin C Sun; Christina J Charlesworth; Nicoleta Lupulescu-Mann; Jenny I Young; Hyunjee Kim; Daniel M Hartung; Richard A Deyo; K John McConnell
Journal:  Ann Emerg Med       Date:  2017-12-13       Impact factor: 5.721

4.  Prescription monitoring programs and emergency department visits involving opioids, 2004-2011.

Authors:  Brandon C Maughan; Marcus A Bachhuber; Nandita Mitra; Joanna L Starrels
Journal:  Drug Alcohol Depend       Date:  2015-09-30       Impact factor: 4.492

5.  Variations in prescription drug monitoring program use by prescriber specialty.

Authors:  Benjamin C Sun; Nicoleta Lupulescu-Mann; Christina J Charlesworth; Hyunjee Kim; Daniel M Hartung; Richard A Deyo; K John McConnell
Journal:  J Subst Abuse Treat       Date:  2018-08-17

Review 6.  A systematic review of strategies to improve appropriate use of opioids and to reduce opioid use disorder and deaths from prescription opioids.

Authors:  Andrea D Furlan; Nancy Carnide; Emma Irvin; Dwayne Van Eerd; Claire Munhall; Jaemin Kim; Cathy Meng Fei Li; Abdul Hamad; Quenby Mahood; Sara MacDonald
Journal:  Can J Pain       Date:  2018-07-31

7.  Evidence for state, community and systems-level prevention strategies to address the opioid crisis.

Authors:  Tamara M Haegerich; Christopher M Jones; Pierre-Olivier Cote; Amber Robinson; Lindsey Ross
Journal:  Drug Alcohol Depend       Date:  2019-09-19       Impact factor: 4.852

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.